Carregant...
How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?
Antibiotics have revolutionized the treatment of bacterial infections. However, it is widely held that there is underinvestment in antibiotics research and development relative to the socially optimal level for a number of reasons. In this article, we discuss whether existing health technology asses...
Guardat en:
| Publicat a: | MDM Policy Pract |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935770/ https://ncbi.nlm.nih.gov/pubmed/31910245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468319892237 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|